Providence, R.I.-based Roger Williams Medical Center is starting a phase Ib clinical trial onCAR-T hepatic artery infusions delivered using the Surefire Infusion System for CEA-expressing liver metastases.
GI & Endoscopy
John Hood, MD, is a gastroenterologist with Tulsa, Okla.-based Gastroenterology Specialists.
Paris, France-based Nanobiotix reported the results of its phase I/II clinical trial for NBTXR3, its liver cancer drug.
Gastroenterologist Jonathan Warman, MD, is the most recent addition to The International Association of HealthCare Professionals' Leading Physicians of the World publication.
Here are four updates on gastroenterology and endoscopy companies.
Advertisement
Alan P. Ganderson, MD, is a gastroenterologist at Gastroenterology of Virginia Beach.
The U.S. Department of Defense honored Pensacola (Fla.) Naval Hospital's Brent Lacey, MD, for his innovative hepatitis C screening program, the Pensacola News Journal reports.
Rolling Meadows, Ill.-based Boston Scientific closed a deal to acquire Vancouver, Canada-based Neovasc for $75 million.
New York-based Tyme Technologies partnered with Rochester, Minn.-based Mayo Clinic to launch a pancreatic research program.
Jung-Whan Kim, a biologist at The University of Texas at Dallas, discovered that two enzymes linked to keeping cancer cells alive, can work in tandem to spur cancer growth.